Alterations of negative regulators of cytokine signalling in immunodeficiency-related non-Hodgkin lymphoma
Autor: | Capello, Daniela, Gloghini, Annunziata, Baldanzi, Gianluca, Martini, Maurizio, Deambrogi, Clara, Lucioni, Marco, Piranda, Daniela, Famà, Rosella, Graziani, Andrea, Spina, Michele, Tirelli, Umberto, Paulli, Marco, Larocca Luigi Maria, Gaidano, Gianluca, Carbone, Antonino, Sinigaglia, Fabiola |
---|---|
Přispěvatelé: | Capello, Daniela, Gloghini, Annunziata, Baldanzi, Gianluca, Martini, Maurizio, Deambrogi, Clara, Lucioni, Marco, Piranda, Daniela, Famà, Rosella, Graziani, Andrea, Spina, Michele, Tirelli, Umberto, Paulli, Marco, Larocca, Luigi Maria, Gaidano, Gianluca, Carbone, Antonino, Sinigaglia, Fabiola |
Jazyk: | angličtina |
Rok vydání: | 2013 |
Předmět: |
Cancer Research
Lymphoma DNA Mutational Analysis Suppressor of Cytokine Signaling Proteins STAT Transcription Factor Cell Line Clonal Evolution DNA Mutational Analysi Neoplasm Protein Immunodeficiency PTPN6/SHP1 SOCS1 SOCS3 Tumor Cytokines DNA Neoplasm Humans Immunocompromised Host Janus Kinases AIDS-Related Lymphoproliferative Disorders Mutation Neoplasm Proteins Organ Transplantation Postoperative Complications Protein Tyrosine Phosphatase Non-Receptor Type 6 Retrospective Studies STAT Transcription Factors Signal Transduction Suppressor of Cytokine Signaling 1 Protein Suppressor of Cytokine Signaling 3 Protein DNA Methylation Hematology Oncology Retrospective Studie Cell Line Tumor Suppressor of Cytokine Signaling Protein Cytokine Lymphoma AIDS-Related Protein Tyrosine Phosphatase Non-Receptor Type 6 DNA Neoplasm Lymphoproliferative Disorder Janus Kinase Postoperative Complication Human |
Popis: | We investigated immunodeficiency-related non-Hodgkin lymphoma for the presence of molecular alterations affecting negative regulators of the Janus family protein tyrosine kinase/signal transducer and activator of transcription pathway. Protein tyrosine phosphatase, non-receptor type 6/Src homology 2-containing tyrosine phosphatase-1 epigenetic silencing was recurrent in primary effusion lymphoma (100%), and diffuse large B-cell lymphoma (63%), with a higher prevalence in the non-germinal centre subtype, and was associated with the activation of the Janus family protein tyrosine kinase/signal transducer and activator of transcription 3 pathway. Suppressor of cytokine signalling (SOCS)1 and SOCS3 epigenetic silencing were occasionally detected, whereas SOCS1 was frequently mutated in diffuse large B-cell lymphoma and polymorphic post-transplant lymphoproliferative disorders, possibly as a cause of aberrant somatic hypermutation. However, the mutation profile of the coding region of the gene was different from that expected from the aberrant somatic hypermutation process, suggesting that, at least in some cases, SOCS1 mutations may have been selected for their functional activity. © 2012 John Wiley & Sons, Ltd. |
Databáze: | OpenAIRE |
Externí odkaz: |